{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T18:26:24Z","timestamp":1793989584840,"version":"4.8.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":38,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiovascular Magnetic Resonance"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.jocmr.2025.101859","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T12:10:03Z","timestamp":1739362203000},"page":"101859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic value of bone scintigraphy versus cardiovascular magnetic resonance in cardiac amyloidosis"],"prefix":"10.1016","volume":"27","author":[{"given":"Josefin","family":"Obergassel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bietenbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuriye","family":"Akyol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Vehof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Theofanidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Stalling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.jocmr.2025.101859_bib1","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1161\/CIRCULATIONAHA.122.060852","article-title":"Impact of earlier diagnosis in cardiac ATTR amyloidosis over the course of 20 years","volume":"146","author":"Ioannou","year":"2022","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jocmr.2025.101859_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00392-022-02114-y","article-title":"Epidemiology of cardiac amyloidosis in Germany: a retrospective analysis from 2009 to 2018","volume":"112","author":"Ney","year":"2023","journal-title":"Clin Res Cardiol"},{"issue":"3","key":"10.1016\/j.jocmr.2025.101859_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00392-022-02035-w","article-title":"Therapeutic value of tafamidis in patients with wild-type transthyretin amyloidosis (ATTRwt) with cardiomyopathy based on cardiovascular magnetic resonance (CMR) imaging","volume":"112","author":"Chamling","year":"2023","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"10.1016\/j.jocmr.2025.101859_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2305434","article-title":"Efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy","volume":"390","author":"Gillmore","year":"2024","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.jocmr.2025.101859_bib5","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1056\/NEJMoa2300757","article-title":"Patisiran treatment in patients with transthyretin cardiac amyloidosis","volume":"389","author":"Maurer","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jocmr.2025.101859_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa2303765","article-title":"Phase 1 trial of antibody NI006 for depletion of cardiac transthyretin amyloid","volume":"389","author":"Garcia-Pavia","year":"2023","journal-title":"N Engl J Med"},{"issue":"37","key":"10.1016\/j.jocmr.2025.101859_bib7","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.jocmr.2025.101859_bib8","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology solution set oversight committee","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jocmr.2025.101859_bib9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00392-020-01799-3","article-title":"Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK)","volume":"110","author":"Yilmaz","year":"2021","journal-title":"Clin Res Cardiol"},{"issue":"24","key":"10.1016\/j.jocmr.2025.101859_bib10","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jocmr.2025.101859_bib11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2147\/VHRM.S295376","article-title":"Diagnostic work-up of cardiac amyloidosis using cardiovascular imaging: current standards and practical algorithms","volume":"17","author":"Korosoglou","year":"2021","journal-title":"Vasc Health Risk Manag"},{"issue":"4","key":"10.1016\/j.jocmr.2025.101859_bib12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00392-020-01771-1","article-title":"Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study","volume":"110","author":"Chatzantonis","year":"2021","journal-title":"Clin Res Cardiol"},{"issue":"24","key":"10.1016\/j.jocmr.2025.101859_bib13","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/eurheartj\/ehad139","article-title":"Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis","volume":"44","author":"Rauf","year":"2023","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jocmr.2025.101859_bib14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jcmg.2022.07.008","article-title":"Multi-imaging characterization of cardiac phenotype in different types of amyloidosis","volume":"16","author":"Ioannou","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"issue":"12","key":"10.1016\/j.jocmr.2025.101859_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024717","article-title":"Correlation between cardiac images, biomarkers, and amyloid load in wild-type transthyretin amyloid cardiomyopathy","volume":"11","author":"Morioka","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.jocmr.2025.101859_bib16","doi-asserted-by":"crossref","first-page":"15521","DOI":"10.1038\/s41598-021-94650-2","article-title":"CMR-based T1-mapping offers superior diagnostic value compared to longitudinal strain-based assessment of relative apical sparing in cardiac amyloidosis","volume":"11","author":"Korthals","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jocmr.2025.101859_bib17","doi-asserted-by":"crossref","first-page":"21755","DOI":"10.1038\/s41598-022-26216-9","article-title":"A compartment-based myocardial density approach helps to solve the native T1 vs. ECV paradox in cardiac amyloidosis","volume":"12","author":"Chamling","year":"2022","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.jocmr.2025.101859_bib18","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","article-title":"Native T1 and extracellular volume in transthyretin amyloidosis","volume":"12","author":"Martinez-Naharro","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.jocmr.2025.101859_bib19","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jcmg.2018.03.029","article-title":"The \u201cnative T1 versus extracellular volume fraction paradox\u201d in cardiac amyloidosis: answer to the million-dollar question?","volume":"12","author":"Yilmaz","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2025.101859_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/jcm12247605","article-title":"Lights and shadows of clinical applications of cardiac scintigraphy with bone tracers in suspected amyloidosis","volume":"12","author":"Saro","year":"2023","journal-title":"J Clin Med"},{"issue":"40","key":"10.1016\/j.jocmr.2025.101859_bib21","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"}],"container-title":["Journal of Cardiovascular Magnetic Resonance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664725000213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664725000213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:54:49Z","timestamp":1793987689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1097664725000213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"alternative-id":["S1097664725000213"],"URL":"https:\/\/doi.org\/10.1016\/j.jocmr.2025.101859","relation":{},"ISSN":["1097-6647"],"issn-type":[{"value":"1097-6647","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic value of bone scintigraphy versus cardiovascular magnetic resonance in cardiac amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiovascular Magnetic Resonance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocmr.2025.101859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of Society for Cardiovascular Magnetic Resonance.","name":"copyright","label":"Copyright"}],"article-number":"101859"}}